1.
Belgische en Franse "real world evidence" over de doeltreffendheid en tolerantie van guselkumab bij matige tot ernstige plaque psoriasis
2.
3.
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO : Be...
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO : Belgian Evidence-based T...
Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: A Belgian retrospective multicentre study
Disease severity in moderate‐to‐severe plaque psoriasis: Results from the Belgian REDISCOVER study
Real-life effectiveness of apremilast for the treatment of psoriasis in Belgium : results from the observational OTELO study
Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study
Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study
Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study.
4.
5.
6.
7.
A Belgian Consensus On The Definition Of A Treatâ€Toâ€Target Outcome Set In Psoriasis Management
